Huang, Hsuan-Ying <br/><br/>
ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jun 2013 
 - 2861-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-2641  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amino-Acid N-Acetyltransferase--biosynthesis<br/>Animals<br/>Argininosuccinate Synthase--deficiency<br/>Cell Line, Tumor<br/>Cell Movement--genetics<br/>Cell Proliferation<br/>Cell Survival--drug effects<br/>Cluster Analysis<br/>DNA Methylation<br/>Female<br/>Fibrosarcoma--drug therapy<br/>G1 Phase Cell Cycle Checkpoints--genetics<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Gene Knockdown Techniques<br/>Genes, Tumor Suppressor<br/>Humans<br/>Hydrolases--administration & dosage<br/>Leiomyosarcoma--drug therapy<br/>Male<br/>Mice<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Invasiveness<br/>Neoplasm Staging<br/>Neovascularization, Pathologic--genetics<br/>Phenotype<br/>Polyethylene Glycols--administration & dosage<br/>Prognosis<br/>Xenograft Model Antitumor Assays